SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker

Mutations of the p53 gene hallmark many human cancers. Several p53 mutant proteins acquire the capability to promote cancer progression and metastasis, a phenomenon defined as Gain of Oncogenic Function (GOF). The downstream targets by which GOF p53 mutants perturb cellular programs relevant to onco...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kolukula, Vamsi K., Sahu, Geetaram, Wellstein, Anton, Rodriguez, Olga C., Preet, Anju, Iacobazzi, Vito, D'Orazi, Gabriella, Albanese, Chris, Palmieri, Ferdinando, Avantaggiati, Maria Laura
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2014
Témata:
Priority Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4012738/
https://ncbi.nlm.nih.gov/pubmed/24681808
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky